Patent details

Basic Information

Publication number:

EP0969815

PCT Application Number:

PCT/EP/1998/001626

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP989191200

PCT Publication Number:

WO/1998/042321

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITIONS

French Title of Invention:

COMPOSITIONS PHARMACEUTIQUES

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN

SPC Number:

Dates

Filing date:

20/03/1998

Grant date:

11/05/2005

EP Publication Date:

11/05/2005

PCT Publication Date:

01/10/1998

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/01/2000

EP B1 Publication Date:

11/05/2005

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

20/03/2018

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/03/1998

 

 

Name:

GLAXO GROUP LIMITED

Address:

Glaxo Wellcome House Berkeley Avenue, Greenford, Middlesex UB6 ONN, United Kingdom (GB)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

11/05/2005

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

NGUYEN Ngoc-Anh, Thi

Address:

United States (US)

2

Name:

CASEY Warren, M.

Address:

United States (US)

Priority

1

Priority Number:

42353 P

Priority Date:

24/03/1997

Priority Country:

United States (US)

2

Priority Number:

9706295

Priority Date:

26/03/1997

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

A61K 9/08;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

07/03/2017

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

MDC (HENKEL PATENT)

Filing date	Document type	Number of pages